[CITATION][C] SOLO1 investigators. Overall survival with maintenance olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a …

P DiSilvestro, S Banerjee, N Colombo, G Scambia… - J. Clin. Oncol., 2022